Pages that link to "Q53118752"
Jump to navigation
Jump to search
The following pages link to Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia. (Q53118752):
Displaying 10 items.
- Diagnosis and management of paraneoplastic neurologic disorders (Q26853598) (← links)
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue (Q30276550) (← links)
- Isaacs' syndrome in pregnancy (Q34329864) (← links)
- Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome (Q34437216) (← links)
- Clinical characteristics and therapeutic evaluation of childhood myasthenia gravis (Q35159667) (← links)
- Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients (Q38306801) (← links)
- Small Quaternary Inhibitors K298 and K524: Cholinesterases Inhibition, Absorption, Brain Distribution, and Toxicity (Q40233361) (← links)
- Antiglycine receptor antibody and encephalomyelitis with rigidity and myoclonus (PERM) related to small cell lung cancer (Q41952963) (← links)
- Spontaneous Remission of Isaacs’ Syndrome (Q90081639) (← links)
- Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome (Q91931025) (← links)